1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Wang, G. Pierens, G.K. Treleaven, W.D. Sparrow, J.T. Cushley, R.J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 35 10358 10366 10.1021/bi960934t 8756691 Conformations of human apolipoprotein E(263-286) and E(267-289) in aqueous solutions of sodium dodecyl sulfate by CD and 1H NMR. 1996 10.2210/pdb1oeg/pdb pdb_00001oeg 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 2527.890 APOLIPOPROTEIN E RESIDUES 267 - 289 1 man polymer APOE(267-289), APOLIPOPROTEIN E(267-289) no no PLVEDMQRQWAGLVEKVQAAVGT PLVEDMQRQWAGLVEKVQAAVGT A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n human Homo sample 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1996-12-07 1 1 2008-03-03 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1996-03-16 REL REL 5 6.0 310 K HAVEL refinement DGII PRO 267 n 1 PRO 267 A LEU 268 n 2 LEU 268 A VAL 269 n 3 VAL 269 A GLU 270 n 4 GLU 270 A ASP 271 n 5 ASP 271 A MET 272 n 6 MET 272 A GLN 273 n 7 GLN 273 A ARG 274 n 8 ARG 274 A GLN 275 n 9 GLN 275 A TRP 276 n 10 TRP 276 A ALA 277 n 11 ALA 277 A GLY 278 n 12 GLY 278 A LEU 279 n 13 LEU 279 A VAL 280 n 14 VAL 280 A GLU 281 n 15 GLU 281 A LYS 282 n 16 LYS 282 A VAL 283 n 17 VAL 283 A GLN 284 n 18 GLN 284 A ALA 285 n 19 ALA 285 A ALA 286 n 20 ALA 286 A VAL 287 n 21 VAL 287 A GLY 288 n 22 GLY 288 A THR 289 n 23 THR 289 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 4 A A HD13 HB3 LEU ASP 268 271 1.21 1 -5.50 0.90 118.30 112.80 A A A CB CG OD2 ASP ASP ASP 271 271 271 N 1 4.04 0.50 120.30 124.34 A A A NE CZ NH1 ARG ARG ARG 274 274 274 N 2 -5.47 0.90 118.30 112.83 A A A CB CG OD2 ASP ASP ASP 271 271 271 N 2 4.01 0.50 120.30 124.31 A A A NE CZ NH1 ARG ARG ARG 274 274 274 N 3 -5.52 0.90 118.30 112.78 A A A CB CG OD1 ASP ASP ASP 271 271 271 N 3 4.03 0.50 120.30 124.33 A A A NE CZ NH1 ARG ARG ARG 274 274 274 N 4 -5.45 0.90 118.30 112.85 A A A CB CG OD2 ASP ASP ASP 271 271 271 N 4 4.08 0.50 120.30 124.38 A A A NE CZ NH1 ARG ARG ARG 274 274 274 N 5 -5.46 0.90 118.30 112.84 A A A CB CG OD2 ASP ASP ASP 271 271 271 N 5 4.08 0.50 120.30 124.38 A A A NE CZ NH1 ARG ARG ARG 274 274 274 N 1 A A CD OE2 GLU GLU 270 270 0.110 0.011 1.252 1.362 N 1 A A CD OE2 GLU GLU 281 281 0.109 0.011 1.252 1.361 N 2 A A CD OE2 GLU GLU 270 270 0.109 0.011 1.252 1.361 N 2 A A CD OE2 GLU GLU 281 281 0.110 0.011 1.252 1.362 N 3 A A CD OE2 GLU GLU 270 270 0.110 0.011 1.252 1.362 N 3 A A CD OE1 GLU GLU 281 281 0.110 0.011 1.252 1.362 N 4 A A CD OE1 GLU GLU 270 270 0.109 0.011 1.252 1.361 N 4 A A CD OE2 GLU GLU 281 281 0.110 0.011 1.252 1.362 N 5 A A CD OE2 GLU GLU 270 270 0.110 0.011 1.252 1.362 N 5 A A CD OE2 GLU GLU 281 281 0.109 0.011 1.252 1.361 N 1 A ARG 274 -160.60 -64.27 2 A GLU 270 -92.50 32.54 2 A ASP 271 -152.65 37.13 2 A MET 272 -155.42 29.86 2 A GLN 273 -154.82 36.70 2 A ARG 274 -159.68 -63.40 2 A VAL 287 42.50 70.75 3 A LEU 268 -99.67 33.28 3 A VAL 269 -147.80 -49.07 3 A ASP 271 -95.83 33.78 3 A MET 272 -148.34 28.53 3 A GLN 273 -159.61 46.54 3 A ARG 274 -155.54 -66.54 4 A LEU 268 -94.91 -106.69 4 A VAL 269 49.37 21.98 4 A GLU 270 -142.26 -49.13 4 A GLN 273 -153.13 45.08 4 A ARG 274 -153.56 -68.95 4 A VAL 280 -125.94 -56.84 5 A GLN 273 -148.96 40.31 5 A ARG 274 -152.45 -64.20 PEPTIDE OF HUMAN APOE RESIDUES 267-289, NMR, 5 STRUCTURES AT PH 6.0, 37 DEGREES CELSIUS AND PEPTIDE:SDS MOLE RATIO OF 1:90 1 Y N A LEU 268 A LEU 2 HELX_P A ASP 271 A ASP 5 1 1 4 A GLN 275 A GLN 9 HELX_P A ALA 286 A ALA 20 1 2 12 APOLIPOPROTEIN SIALIC ACID, HEPARIN-BINDING, DISEASE MUTATION, POLYMORPHISM, APOLIPOPROTEIN APOE_HUMAN UNP 1 1 P02649 MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRA LMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLR KLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMG SRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH 285 307 1OEG 267 289 P02649 A 1 1 23 1 P 1